A Clinical Trial of "B-663" in Vitiligo
|How to cite this article:
Handa F, Ahmad M. A Clinical Trial of "B-663" in Vitiligo. Indian J Dermatol Venereol Leprol 1980;46:338-340
Abstract'B663' (3-P chloranilino) - 10 (P-Chlorophenyl) - 2, 10-dihydro-2-(ISO-prophylimino) (lampre-ne, Hansepran) was tried in 20 pmknts with vitiligo. Majority of cam (I 7) did not show any improvement Three cases showed slight repigmentation. Generalised dark brown pigmentation was a major deterrent for the patients to use this drug. Good results claimed in a previous report, could not be substantiated by us.